Literature DB >> 19793983

Involvement of actin rearrangements within the amygdala and the dorsal hippocampus in aversive memories of drug withdrawal in acute morphine-dependent rats.

Yuan-Yuan Hou1, Bin Lu, Mu Li, Yao Liu, Jie Chen, Zhi-Qiang Chi, Jing-Gen Liu.   

Abstract

Aversive memories of drug withdrawal can generate a motivational state leading to compulsive drug taking. Changes in synaptic plasticity may be involved in the formation of aversive memories. Dynamic rearrangement of the cytoskeletal actin, a major structural component of the dendritic spine, regulates synaptic plasticity. Here, the potential involvement of actin rearrangements in the induction of aversive memories of morphine withdrawal was examined. We found that lesions of the amygdala or dorsal hippocampus (DH) but not nucleus accumbens (NAc) impaired conditioned place aversion (CPA) of acute morphine-dependent rats. Accordingly, conditioned morphine withdrawal induced actin rearrangements in the amygdala and the DH but not in the NAc. In addition, we found that conditioned morphine withdrawal also increased activity-regulated cytoskeletal-associated protein (Arc) expression in the amygdala but not in the DH, although actin rearrangements were observed in both areas. We further found that inhibition of actin rearrangements by intra-amygdala or intra-DH injections of latrunculin A, an inhibitor of actin polymerization, significantly attenuated CPA. Furthermore, we found that manipulation of amygdala beta-adrenoceptor activity by its antagonist propranolol and agonist clenbuterol differentially altered actin rearrangements in the DH. Therefore, our findings reveal that actin rearrangements in the amygdala and the DH are required for the acquisition and consolidation of the aversive memories of drug withdrawal and that the beta-noradrenergic system within the amygdala modulates aversive memory consolidation by regulating actin rearrangements but not Arc protein expression in the DH, which is distinct from its role in modulation of inhibitory avoidance memory.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19793983      PMCID: PMC6666133          DOI: 10.1523/JNEUROSCI.1970-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  27 in total

1.  Selective, retrieval-independent disruption of methamphetamine-associated memory by actin depolymerization.

Authors:  Erica J Young; Massimiliano Aceti; Erica M Griggs; Rita A Fuchs; Zachary Zigmond; Gavin Rumbaugh; Courtney A Miller
Journal:  Biol Psychiatry       Date:  2013-09-05       Impact factor: 13.382

2.  Glucocorticoid Homeostasis in the Dentate Gyrus Is Essential for Opiate Withdrawal-Associated Memories.

Authors:  Daniel García-Pérez; Szilamer Ferenczi; Krisztina J Kovács; M Luisa Laorden; M Victoria Milanés; Cristina Núñez
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

3.  Long-term changes in reward-seeking following morphine withdrawal are associated with altered N-methyl-D-aspartate receptor 1 splice variants in the amygdala.

Authors:  E M Anderson; J K Neubert; R M Caudle
Journal:  Neuroscience       Date:  2012-08-02       Impact factor: 3.590

Review 4.  The Actin Cytoskeleton as a Therapeutic Target for the Prevention of Relapse to Methamphetamine Use.

Authors:  Erica J Young; Sherri B Briggs; Courtney A Miller
Journal:  CNS Neurol Disord Drug Targets       Date:  2015       Impact factor: 4.388

5.  CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats.

Authors:  Kiri L Wills; Kiran Vemuri; Alana Kalmar; Alan Lee; Cheryl L Limebeer; Alexandros Makriyannis; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2014-04-27       Impact factor: 4.530

6.  Morphine modulates mouse hippocampal progenitor cell lineages by upregulating miR-181a level.

Authors:  Chi Xu; Yue Zhang; Hui Zheng; Horace H Loh; Ping-Yee Law
Journal:  Stem Cells       Date:  2014-11       Impact factor: 6.277

7.  A novel brain penetrant NPS receptor antagonist, NCGC00185684, blocks alcohol-induced ERK-phosphorylation in the central amygdala and decreases operant alcohol self-administration in rats.

Authors:  Annika Thorsell; Jenica D Tapocik; Ke Liu; Michelle Zook; Lauren Bell; Meghan Flanigan; Samarjit Patnaik; Juan Marugan; Ruslan Damadzic; Seameen J Dehdashti; Melanie L Schwandt; Noel Southall; Christopher P Austin; Robert Eskay; Roberto Ciccocioppo; Wei Zheng; Markus Heilig
Journal:  J Neurosci       Date:  2013-06-12       Impact factor: 6.167

8.  Dorsal hippocampal NMDA receptor blockade impairs extinction of naloxone-precipitated conditioned place aversion in acute morphine-treated rats by suppressing ERK and CREB phosphorylation in the basolateral amygdala.

Authors:  Wei-Sheng Wang; Zhong-Guo Chen; Wen-Tao Liu; Zhi-Qiang Chi; Ling He; Jing-Gen Liu
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

9.  Formation of aversive memories associated with conditioned drug withdrawal requires BDNF expression in the amygdala in acute morphine-dependent rats.

Authors:  Yun-yue Ju; Jian-dong Long; Yao Liu; Jing-gen Liu
Journal:  Acta Pharmacol Sin       Date:  2015-11-16       Impact factor: 6.150

10.  The small GTPase RhoA, but not Rac1, is essential for conditioned aversive memory formation through regulation of actin rearrangements in rat dorsal hippocampus.

Authors:  Jun Wang; Yu-hua Wang; Yuan-yuan Hou; Tao Xi; Yao Liu; Jing-gen Liu
Journal:  Acta Pharmacol Sin       Date:  2013-04-08       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.